Kobayashi Pharmaceutical Co., Ltd. (FRA:KOY)
Germany
· Delayed Price · Currency is EUR 32.60
-0.20 (-0.61%)
At close: Apr 25, 2025, 10:00 PM CET
Kobayashi Pharmaceutical Revenue
In the year 2024, Kobayashi Pharmaceutical had annual revenue of 165.60B JPY, down -4.53%. Kobayashi Pharmaceutical had revenue of 51.14B in the quarter ending December 31, 2024, a decrease of -5.89%.
Revenue
165.60B JPY
Revenue Growth
-4.53%
P/S Ratio
2.43
Revenue / Employee
45.81M JPY
Employees
3,615
Market Cap
2.48B EUR
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 165.60B | -7.86B | -4.53% |
| Dec 31, 2023 | 173.46B | 7.20B | 4.33% |
| Dec 31, 2022 | 166.26B | 11.01B | 7.09% |
| Dec 31, 2021 | 155.25B | 4.74B | 3.15% |
| Dec 31, 2020 | 150.51B | -17.54B | -10.44% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.15B |
| Siemens Aktiengesellschaft | 76.54B |
| Deutsche Telekom AG | 118.43B |
| Allianz SE | 107.35B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.15B |
| Rheinmetall AG | 9.75B |
| Siemens Energy AG | 35.76B |
| Merck KGaA | 21.16B |